Dexcel Pharma Drug Patent Portfolio
Dexcel Pharma owns 1 orange book drug protected by 1 US patent Given below is the list of Dexcel Pharma's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US9023391 | Stable benzimidazole formulation | 16 Aug, 2025 | Active |
Latest Legal Activities on Dexcel Pharma's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Dexcel Pharma.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 4th Year, Large Entity | 09 May, 2024 | US10835488 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 26 Oct, 2022 | US9023391 (Litigated) |
| Payment of Maintenance Fee, 4th Year, Large Entity | 14 Feb, 2022 | US10076494 |
|
Recordation of Patent Grant Mailed
Critical
| 17 Nov, 2020 | US10835488 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 17 Nov, 2020 | US10835488 |
|
Email Notification
Critical
| 29 Oct, 2020 | US10835488 |
|
Issue Notification Mailed
Critical
| 28 Oct, 2020 | US10835488 |
| Mailing Corrected Notice of Allowability | 13 Oct, 2020 | US10835488 |
|
Email Notification
Critical
| 13 Oct, 2020 | US10835488 |
| Dispatch to FDC | 10 Oct, 2020 | US10835488 |
|
Information Disclosure Statement considered
Critical
| 07 Oct, 2020 | US10835488 |
| Corrected Notice of Allowability | 07 Oct, 2020 | US10835488 |
|
Pubs Case Remand to TC
Critical
| 05 Oct, 2020 | US10835488 |
| Record Petition Decision of Granted to Withdraw from Issue | 17 Sep, 2020 | US10835488 |
| Workflow - Request for RCE - Finish | 17 Sep, 2020 | US10835488 |
Dexcel Pharma's Family Patents
Dexcel Pharma drugs have patent protection in a total of 8 countries. It's US patent count contributes only to 35.7% of its total global patent coverage. 7 countries have all of their patents expired or invalidated which has opened up potential generic launch opportunities in these countries. Click
below to unlock the full patent family tree.
Dexcel Pharma Drug List
Given below is the complete list of Dexcel Pharma's drugs and the patents protecting them.
1. Omeprazole
Omeprazole is protected by 1 patent, which is still active. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US9023391 | Stable benzimidazole formulation |
16 Aug, 2025
(10 months from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Omeprazole's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List